{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:22:33Z","timestamp":1790446953475,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer disease (AD) and Parkinson disease (PD) are an increasing healthcare concern and growing cause of disability in our century. The advent of the artificial intelligence (AI) era and the early changes in retina and optic nerve morphology detected in neurodegenerative diseases by recent literature opened the way to the perspective of a AI-based diagnosis for both conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>In AD a generalized decrease in macular Ganglion Cells-Inner Plexiform Layer (GC-IPL) and retinal nerve fiber layer (RNFL) and peripapillary RNFL thickness has been documented. Moreover, clinical AD is characterized by a lower choroidal thickness and higher choroidal vascularity index. AI can be predicted with around 80% accuracy based on small fundus vessels characteristics. Similarly, AI based on Optical Coherence Tomography (OCT) images showed very good performance in detecting AD, especially based on total macular volume (TVM) and GCL thickness. A combination of OCT and color fundus photographs (CFP) imaging reached 85% accuracy in detecting MCI. In PD typical retinal anomalies include a generalized thinning of the peripapillary RNFL with a degeneration pattern similar to the one of mitochondrial optic neuropathies, foveal pit widening, generalized retinal and retinal pigmented epithelium thinning and outer plexiform layer thickening. AI CFP-based detection of PD showed only 65% accuracy due to a low specificity, while multimodal imaging-based AI was the best approach, reaching a 100% sensitivity and 85% specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In consideration of the overall very good performance, AD and PD are likely to benefit from the support of retinal-imaging based AI for early diagnosis. To optimize the performance, especially in terms of specificity, the use of multimodal imaging and possible integration with meta-data has been demonstrated to be the best technique, especially for PD diagnosis. However, training and testing on a larger sample size and longitudinal evaluation of the chosen models will be needed before application on general population. So far, explainability of the proposed models seems robust and coherent with the corresponding central nervous system damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00807-4","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:35:04Z","timestamp":1779197704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Artificial intelligence and neurodegeneration: state of the art and explainability"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9996-9871","authenticated-orcid":false,"given":"Emanuele","family":"Crincoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Mario","family":"Carl\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Giannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislao","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"2","key":"807_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"3","key":"807_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of parkinson\u2019s disease in the united States. Mov Disord. 2013;28(3):311\u20138.","journal-title":"Mov Disord"},{"issue":"8 Suppl","key":"807_CR3","first-page":"S177","volume":"26","author":"W Wong","year":"2020","unstructured":"Wong W. Economic burden of alzheimer disease and managed care considerations. Am J Manag Care. 2020;26(8 Suppl):S177\u201383.","journal-title":"Am J Manag Care"},{"issue":"12","key":"807_CR4","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/mds.23878","volume":"26","author":"JP Bach","year":"2011","unstructured":"Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord. 2011;26(12):2286\u201390.","journal-title":"Mov Disord"},{"issue":"2","key":"807_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jalz.2017.10.009","volume":"14","author":"R Brookmeyer","year":"2018","unstructured":"Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical alzheimer\u2019s disease in the united States. Alzheimer\u2019s Dement. 2018;14(2):121\u20139.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"807_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/mds.25097","volume":"27","author":"C Dotchin","year":"2012","unstructured":"Dotchin C, Jusabani A, Gray WK, Walker R. Projected numbers of people with movement disorders in the years 2030 and 2050: implications for sub-Saharan Africa, using essential tremor and parkinson\u2019s disease in Tanzania as an example. Mov Disord. 2012;27(9):1204\u20135.","journal-title":"Mov Disord"},{"key":"807_CR7","doi-asserted-by":"crossref","unstructured":"Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D, et al. Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach. eClinicalMedicine 2022;51:101581. Available from: https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589-5370(22)00310-8\/fulltext.","DOI":"10.1016\/j.eclinm.2022.101580"},{"issue":"4","key":"807_CR8","doi-asserted-by":"publisher","first-page":"227990362211276","DOI":"10.1177\/22799036221127627","volume":"11","author":"BA Nichol","year":"2022","unstructured":"Nichol BA, Hurlbert AC, Read JC. Predicting attitudes towards screening for neurodegenerative diseases using OCT and artificial intelligence: findings from a literature review. J Public Health Res. 2022;11(4):22799036221127627.","journal-title":"J Public Health Res"},{"issue":"1","key":"807_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410220105","volume":"22","author":"SG Diamond","year":"1987","unstructured":"Diamond SG, Marchkham CH, Hoehn MM, McDowell FH, Muenter MD. Multi-center study of Parkinson mortality with early versus later Dopa treatment. Ann Neurol. 1987;22(1):8\u201312.","journal-title":"Ann Neurol"},{"issue":"2","key":"807_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","volume":"32","author":"GE Vitek","year":"2023","unstructured":"Vitek GE, Decourt B, Sabbagh MN. Lecanemab (BAN2401): an anti\u2013beta-amyloid monoclonal antibody for the treatment of alzheimer disease. Expert Opin Investig Drugs. 2023;32(2):89\u201394.","journal-title":"Expert Opin Investig Drugs"},{"key":"807_CR11","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo A, Muzikansky A, G\u00f3mez-Isla T, Growdon JH, Betensky RA, Frosch MP, et al. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol. 2013 June;72(6):462\u201371.","DOI":"10.1097\/NEN.0b013e3182933788"},{"issue":"2","key":"807_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0161-6420(03)00732-2","volume":"111","author":"AG Lee","year":"2004","unstructured":"Lee AG, Martin CO. Neuro-ophthalmic findings in the visual variant of alzheimer\u2019s disease. Ophthalmology. 2004;111(2):376\u201380. discussion 380\u2013381.","journal-title":"Ophthalmology"},{"issue":"2","key":"807_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/APO.0000000000000505","volume":"11","author":"A Yuan","year":"2022","unstructured":"Yuan A, Lee CS. Retinal biomarkers for alzheimer disease: the facts and the future. Asia-Pacific J Ophthalmol. 2022;11(2):140\u20138.","journal-title":"Asia-Pacific J Ophthalmol"},{"issue":"1","key":"807_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altina\u015f O, Tokay T, Y\u00fcksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in alzheimer disease. J Neuroophthalmol. 2006;26(1):18\u201324.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"807_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"CYlui Cheung","year":"2015","unstructured":"Cheung CYlui, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and alzheimer\u2019s disease. J Alzheimers Dis. 2015;45(1):45\u201356.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"807_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-180070","volume":"64","author":"Y Shao","year":"2018","unstructured":"Shao Y, Jiang H, Wei Y, Shi Y, Shi C, Wright CB, et al. Visualization of focal thinning of the ganglion Cell-Inner plexiform layer in patients with mild cognitive impairment and alzheimer\u2019s disease. J Alzheimers Dis. 2018;64(4):1261\u201373.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"807_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723\u201338.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"807_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-132039","volume":"40","author":"M Gharbiya","year":"2014","unstructured":"Gharbiya M, Trebbastoni A, Parisi F, Manganiello S, Cruciani F, D\u2019Antonio F, et al. Choroidal thinning as a new finding in alzheimer\u2019s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40(4):907\u201317.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"807_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41598-020-80312-2","volume":"11","author":"J Tian","year":"2021","unstructured":"Tian J, Smith G, Guo H, Liu B, Pan Z, Wang Z, et al. Modular machine learning for Alzheimer\u2019s disease classification from retinal vasculature. Sci Rep. 2021;11(1):238.","journal-title":"Sci Rep"},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2147\/NDT.S333833","volume":"17","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Li J, Bian M, He Q, Shen Y, Lan Y, et al. Retinal imaging techniques based on machine learning models in recognition and prediction of mild cognitive impairment. Neuropsychiatr Dis Treat. 2021;17:3267\u201381.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"807_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12877-023-04593-8","volume":"24","author":"R Li","year":"2024","unstructured":"Li R, Hui Y, Zhang X, Zhang S, Lv B, Ni Y, et al. Ocular biomarkers of cognitive decline based on deep-learning retinal vessel segmentation. BMC Geriatr. 2024;24(1):28.","journal-title":"BMC Geriatr"},{"issue":"11","key":"807_CR22","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2589-7500(22)00169-8","volume":"4","author":"CY Cheung","year":"2022","unstructured":"Cheung CY, Ran AR, Wang S, Chan VTT, Sham K, Hilal S, et al. A deep learning model for detection of Alzheimer\u2019s disease based on retinal photographs: a retrospective, multicentre case-control study. Lancet Digit Health. 2022;4(11):e806\u201315.","journal-title":"Lancet Digit Health"},{"issue":"12","key":"807_CR23","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/cns.13963","volume":"28","author":"X Wang","year":"2022","unstructured":"Wang X, Jiao B, Liu H, Wang Y, Hao X, Zhu Y, et al. Machine learning based on optical coherence tomography images as a diagnostic tool for Alzheimer\u2019s disease. CNS Neurosci Ther. 2022;28(12):2206\u201317.","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"807_CR24","doi-asserted-by":"publisher","first-page":"e0218826","DOI":"10.1371\/journal.pone.0218826","volume":"14","author":"A Nunes","year":"2019","unstructured":"Nunes A, Silva G, Duque C, Janu\u00e1rio C, Santana I, Ambr\u00f3sio AF, et al. Retinal texture biomarkers May help to discriminate between Alzheimer\u2019s, Parkinson\u2019s, and healthy controls. PLoS ONE. 2019;14(6):e0218826.","journal-title":"PLoS ONE"},{"key":"807_CR25","doi-asserted-by":"publisher","first-page":"107411","DOI":"10.1016\/j.compbiomed.2023.107411","volume":"166","author":"H Gao","year":"2023","unstructured":"Gao H, Zhao S, Zheng G, Wang X, Zhao R, Pan Z, et al. Using a dual-stream attention neural network to characterize mild cognitive impairment based on retinal images. Comput Biol Med. 2023;166:107411.","journal-title":"Comput Biol Med"},{"issue":"3","key":"807_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/bjophthalmol-2020-317659","volume":"106","author":"CE Wisely","year":"2022","unstructured":"Wisely CE, Wang D, Henao R, Grewal DS, Thompson AC, Robbins CB, et al. Convolutional neural network to identify symptomatic Alzheimer\u2019s disease using multimodal retinal imaging. Br J Ophthalmol. 2022;106(3):388\u201395.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"807_CR27","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1167\/iovs.16-20020","volume":"57","author":"A Pilat","year":"2016","unstructured":"Pilat A, McLean RJ, Proudlock FA, Maconachie GDE, Sheth V, Rajabally YA, et al. In vivo morphology of the optic nerve and retina in patients with parkinson\u2019s disease. Invest Ophthalmol Vis Sci. 2016;57(10):4420\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"R2","key":"807_CR28","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1093\/hmg\/ddx273","volume":"26","author":"V Carelli","year":"2017","unstructured":"Carelli V, La Morgia C, Ross-Cisneros FN, Sadun AA. Optic neuropathies: the tip of the neurodegeneration iceberg. Hum Mol Genet. 2017;26(R2):R139\u201350.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"807_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81\u2013114.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"807_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/acn3.146","volume":"2","author":"S Miri","year":"2015","unstructured":"Miri S, Shrier EM, Glazman S, Ding Y, Selesnick I, Kozlowski PB, et al. The avascular zone and neuronal remodeling of the fovea in Parkinson disease. Ann Clin Transl Neurol. 2015;2(2):196\u2013201.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"807_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.42.4.887","volume":"42","author":"MJ Price","year":"1992","unstructured":"Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in parkinson\u2019s disease. Neurology. 1992;42(4):887\u201390.","journal-title":"Neurology"},{"key":"807_CR32","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41598-024-54251-1","volume":"14","author":"C Tran","year":"2024","unstructured":"Tran C, Shen K, Liu K, Ashok A, Ramirez-Zamora A, Chen J, et al. Deep learning predicts prevalent and incident Parkinson\u2019s disease from UK biobank fundus imaging. Sci Rep. 2024;14:3637.","journal-title":"Sci Rep"},{"issue":"8","key":"807_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.13.8.23","volume":"13","author":"A Richardson","year":"2024","unstructured":"Richardson A, Kundu A, Henao R, Lee T, Scott BL, Grewal DS, et al. Multimodal retinal imaging classification for Parkinson\u2019s disease using a convolutional neural network. Transl Vis Sci Technol. 2024;13(8):23.","journal-title":"Transl Vis Sci Technol"},{"key":"807_CR34","unstructured":"Diaz M, Tian J, Fang R. Machine learning for Parkinson\u2019s disease diagnosis using fundus eye images. Annual Meeting of Radiology Society of North America (RSNA) [Internet]. 2020 Dec [cited 2024 Aug 17]; Available from: https:\/\/par.nsf.gov\/biblio\/10296704-machine-learning-parkinsons-disease-diagnosis-using-fundus-eye-images."},{"key":"807_CR35","unstructured":"Chrysou A, Heikka T, van der Zee S, Boertien J, Jansonius N, van Laar T. Identifying de novo Parkinson\u2019s disease with optical coherence tomography of the retina: Movement-Disorder-Society (MDS) International Virtual Congress. Mov Disord. 2020 Sept;35:S238."},{"issue":"3","key":"807_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamaophthalmol.2022.5928","volume":"141","author":"S Ahn","year":"2023","unstructured":"Ahn S, Shin J, Song SJ, Yoon WT, Sagong M, Jeong A, et al. Neurologic dysfunction assessment in Parkinson disease based on fundus photographs using deep learning. JAMA Ophthalmol. 2023;141(3):234\u201340.","journal-title":"JAMA Ophthalmol"},{"issue":"22","key":"807_CR37","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1016\/j.cell.2023.09.012","volume":"186","author":"J Wolf","year":"2023","unstructured":"Wolf J, Rasmussen DK, Sun YJ, Vu JT, Wang E, Espinosa C, et al. Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo. Cell. 2023;186(22):4868\u2013e488412.","journal-title":"Cell"},{"issue":"9","key":"807_CR38","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and Health-Related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"},{"key":"807_CR39","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.preteyeres.2024.101290","volume":"103","author":"VTT Chan","year":"2024","unstructured":"Chan VTT, Ran AR, Wagner SK, Hui HYH, Hu X, Ko H, et al. Value proposition of retinal imaging in alzheimer\u2019s disease screening: A review of eight evolving trends. Prog Retin Eye Res. 2024;103:101290.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"807_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ajo.2010.06.025","volume":"150","author":"A Giani","year":"2010","unstructured":"Giani A, Cigada M, Choudhry N, Deiro AP, Oldani M, Pellegrini M, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150(6):815\u2013e8241.","journal-title":"Am J Ophthalmol"},{"key":"807_CR41","unstructured":"Ethics guidelines for trustworthy AI. | Shaping Europe\u2019s digital future [Internet]. [cited 2025 Dec 12]. Available from: https:\/\/digital-strategy.ec.europa.eu\/en\/library\/ethics-guidelines-trustworthy-ai."},{"key":"807_CR42","doi-asserted-by":"crossref","unstructured":"Petzold A, Albrecht P, Balcer L, Bekkers E, Brandt AU, Calabresi PA, et al. Artificial intelligence extension of the OSCAR-IB criteria. Ann Clin Transl Neurol. 2021 July;8(7):1528\u201342.","DOI":"10.1002\/acn3.51320"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00807-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:03:23Z","timestamp":1784045003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00807-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00807-4","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}